// App-Quantinova.ai

: Feasibility of digital pathology of circulating tumor cells with morphologic analysis in localized bladder cancer.

Researchers

Presenter

  • Heather Chalfin

Principal Investigators

  • Kelly Harris

  • Stephanie Glavaris

  • Michael A. Gorin

  • Max Kates

  • Megan Kearney

  • Adam Jendrisak

  • Megan Fong

  • Andres Matoso

  • Michael Hiroshi Johnson

  • Kenneth J. Pienta

  • Jean H. Hoffman-Censits

  • Vladimir Valera

  • Andrea B. Apolo

  • Trinity Bivalacqua

  • Noah M. Hahn

  • David James McConkey

Medical Centers

  • Radiation Oncology Branch, National Cancer Institute at the National Institutes of Health, Bethesda, MD

  • The Johns Hopkins Hospital, Baltimore, MD

  • Johns Hopkins University School of Medicine, Baltimore, MD

  • Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD

  • The James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD

  • Epic Sciences, Inc., San Diego, CA

  • James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD

  • The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD

  • Radiation Oncology Branch, National Cancer Institute at the National Institutes of Health, Bethesda, MD

  • Gastrointestinal Malignancies Section, Center for Cancer Research, National Cancer Institute at the National Institutes of Health, Bethesda, MD

  • Johns Hopkins University School of Medicine, Baltimore, MD

Locations

  • United States

Companies

  • EPIC SCIENCES, INC.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Bladder Cancer

Biomarkers

  • Circulating tumor cells

  • Cluster of differentiation 45

  • Programmed death-ligand 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved